Physical Medicine & Rehabilitation, Pain Medicine · Spokane, WA
NPI
1609387083
Since 2017
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2607 S Southeast Blvd
Spokane, WA, 99223
Phone (509) 464-6208
Groups this clinician bills Medicare through
Medicare paid, 2024
$235K
2,814 services
Medicare patients, 2024
233
Average age 70
Drug cost, 2024
$694K
9,602 prescriptions
Company payments, 2025
$322
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James L Foster was code 99214 (office e&m - established), 1,451 times for 222 patients. In total James L Foster billed 2,814 services in 11 codes, and Medicare paid $235K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,451 | 222 | $75.98 | $110K |
| 80307 Drug Tests | Office | 549 | 157 | $59.65 | $33K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 298 | 117 | $109.25 | $33K |
| 99484 Behavioral Health Services | Office | 196 | 109 | $32.70 | $6,409 |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 114 | 113 | $233.25 | $27K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 83 | 29 | $194.77 | $16K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 50 | 29 | $153.46 | $7,673 |
| 99211 Office E&M - Established | Office | 43 | 36 | $14.11 | $607 |
| 99204 Office E&M - New | Office | 14 | 14 | $90.46 | $1,266 |
By year: 2022 $172K for 2,071 services; 2023 $226K for 2,812 services; 2024 $235K for 2,814 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 549 | 157 | $59.65 | $33K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 298 | 117 | $109.25 | $33K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 114 | 113 | $233.25 | $27K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 83 | 29 | $194.77 | $16K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 50 | 29 | $153.46 | $7,673 |
Medicare prescription drug claims, 2024
In 2024, the drug James L Foster prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,049 prescriptions and refills. In total James L Foster wrote 9,602 Medicare prescriptions that cost $694K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,049 | 2,052 | 247 | $59K |
| Buprenorphine Generic | 852 | 852 | 111 | $171K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 561 | 561 | 81 | $18K |
| Baclofen Generic | 451 | 492 | 89 | $7,347 |
| Morphine Sulfate Er Morphine Sulfate | 451 | 451 | 59 | $11K |
| Pregabalin Generic | 450 | 470 | 62 | $12K |
| Gabapentin Generic | 418 | 448 | 72 | $6,199 |
| Oxycodone Hcl Generic | 399 | 399 | 68 | $5,909 |
| Tramadol Hcl Generic | 315 | 317 | 47 | $4,717 |
| Cyclobenzaprine Hcl Generic | 262 | 291 | 47 | $3,241 |
| Tizanidine Hcl Generic | 255 | 277 | 50 | $3,784 |
| Methocarbamol Generic | 237 | 276 | 45 | $6,513 |
| Quetiapine Fumarate Generic | 211 | 213 | 30 | $2,845 |
| Belbuca Buprenorphine Hcl | 173 | 173 | 30 | $129K |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 165 | 165 | 26 | $24K |
Brand drugs: 701 claims; generic drugs: 8,901 claims; opioid claims: 5,566.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James L Foster $322 ($322 in general payments such as food, travel and fees) from 3 companies. The largest payer was Collegium Pharmaceutical, Inc. with $221.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.